85 people in Japan died after receiving Pfizer COVID-19 vaccines
- Brief Intermittent Exercise Reduces Heart Disease and Death Risk
- Personalized Lung Tumor Chips Assess PD-1 Therapy Response
- Study Shows Prior Infection Offers Strong Immunity to Original COVID-19 Strain
- Chinese Food Products Dominate Korean Tables Amid Safety Concerns
- Early Detection of Hypopharyngeal Cancer Possible with Saliva Diagnosis
- EB Virus Could Be Infected by Kiss: A Hidden Threat Linked to Cancer
85 people in Japan died after receiving Pfizer COVID-19 vaccines
- AstraZeneca Admits for the First Time that its COVID Vaccine Has Blood Clot Side Effects
- Was COVID virus leaked from the Chinese WIV lab?
- HIV Cure Research: New Study Links Viral DNA Levels to Spontaneous Control
- FDA has mandated a top-level black box warning for all marketed CAR-T therapies
- Can people with high blood pressure eat peanuts?
- What is the difference between dopamine and dobutamine?
- How long can the patient live after heart stent surgery?
85 people in Japan died after receiving Pfizer COVID-19 vaccines.
Overseas Network, May 28. On the 26th local time, the Japanese Ministry of Health, Labour and Welfare announced that 57 people died after being vaccinated with Pfizer’s COVID-19 vaccine between May 3 and 21, and the cumulative death toll increased to 85.
The Ministry of Health, Labour and Welfare has assessed the death cases and stated that there is no need to worry too much about vaccination.
According to a report by Japan’s Yomiuri Shimbun on the 27th, 57 new deaths were reported in their 20s to 90s. The causes of death were mostly stroke and heart failure. More than 80% of the deaths were aged 65. Over the age of. Talking about the causal relationship between vaccination and death, the Ministry of Health, Labour and Welfare stated that 27 of the cases were “unassessable” and the other 30 were “under evaluation.”
As of the 21st, Japan has carried out a total of 8.66 million vaccinations and a total of 85 deaths after the vaccination.
Previous news:
First death case on Feb. 26 after receiving Pfizer vaccine
Japan’s Ministry of Health, Labour and Welfare said on May 2 that a person died after being vaccinated with a vaccine developed by Pfizer Pharmaceuticals in the United States and German BioNtech . This is the first case of death in Japan after being vaccinated with the COVID-19 vaccine.
The Ministry of Health, Labour and Welfare said that a female medical worker in her 60s with no underlying disease was vaccinated with Pfizer on February 26 and died three days later. The cause of death was subarachnoid hemorrhage, but it was impossible to determine whether her death was related to vaccination.
According to statistics from the Japan Broadcasting Association TV station, Japan added 888 new confirmed cases of COVID-19 on the 2nd, with a total of 434,304 confirmed cases; 65 new deaths and a total of 8013 deaths. Data show that the number of new cases in a single day in Japan was less than 1,000 on the second day for the third consecutive day. There were 232 new confirmed cases in Tokyo that day.
The average number of new cases in a single day was about 263 in the last 7 days. The state of emergency in Tokyo and the surrounding 3 counties was originally scheduled to expire on March 7. Prime Minister Yoshihide Suga said that he would listen to the opinions of the governors and experts before determining whether the state of emergency was lifted as scheduled.
Kyodo News reported on the 3rd that Tokyo and the surrounding 3 counties may request an extension of the state of emergency.
Japan launched the COVID-19 vaccination program on February 17, and the first batch will be vaccinated for 40,000 medical staff. As of the 2nd, a total of 34,772 people were vaccinated. There have been two reports of suspected side effects before.
The Ministry of Health, Labour and Welfare hopes to ensure that about 3.7 million other medical staff will be vaccinated against COVID-19 by mid-March, and about 36 million people over 65 years old will be vaccinated after April, followed by those with underlying diseases and ordinary people.
(source:internet, reference only)
Disclaimer of medicaltrend.org
Important Note: The information provided is for informational purposes only and should not be considered as medical advice.